Lyons, France

Alexis Guy André Lucien Parisot


 

Average Co-Inventor Count = 5.9

ph-index = 1


Company Filing History:


Years Active: 2020-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Inventor Alexis Guy André Lucien Parisot: Pioneering Immunogenic Formulations**

Introduction

Alexis Guy André Lucien Parisot is an accomplished inventor based in Lyons, France. He is recognized for his innovative contributions to the field of immunology, particularly in developing vaccine formulations that utilize novel polymer adjuvants. His work has the potential to greatly enhance vaccine efficacy across a variety of species.

Latest Patents

Parisot holds a patent for "Immunogenic formulations comprising linear or branched polyacrylic acid polymer adjuvants." This significant invention presents novel immunological and vaccine formulations that incorporate a non-crosslinked polyacrylic acid polymer adjuvant. The versatility of these adjuvants allows for their combination with various immunogens, ensuring safety and effectiveness when administered to a wide range of target animals, including humans and various domestic species.

Career Highlights

Throughout his career, Parisot has contributed to prominent companies in the pharmaceutical and animal health sectors. Notably, he has worked with Sanofi Pasteur, a leader in vaccine development, and Boehringer Ingelheim Animal Health USA Inc., which focuses on enhancing the health and well-being of animals.

Collaborations

In his endeavors, Parisot has collaborated with notable colleagues, including Guillaume Rigaut and Karelle De Luca. Working alongside these talented individuals has allowed for the advancement of innovative research and development in immunogenic formulations.

Conclusion

Alexis Guy André Lucien Parisot is a key figure in the innovation of vaccine technologies, with a strong emphasis on improving immunogenic formulations. His inventive work, supported by his collaborations and career experiences, continues to pave the way for advancements in veterinary and human medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…